Annotation Detail
Information
- Associated Genes
- ESR2
- Associated Variants
-
ESR2 p.Val328= (p.V328=)
(
ENST00000556275.5,
ENST00000553796.5,
ENST00000353772.7,
ENST00000341099.6,
ENST00000554572.5,
ENST00000555278.5,
ENST00000557772.5,
ENST00000358599.9,
ENST00000267525.10 )
ESR1 c.453-351A>G ( ENST00000206249.8, ENST00000338799.9, ENST00000406599.5, ENST00000427531.6, ENST00000440973.5, ENST00000443427.5, ENST00000456483.3 )
ESR2 p.Val328= (p.V328=) ( ENST00000267525.10, ENST00000341099.6, ENST00000353772.7, ENST00000358599.9, ENST00000553796.5, ENST00000554572.5, ENST00000555278.5, ENST00000556275.5, ENST00000557772.5 )
ESR1 c.453-351A>G ( ENST00000206249.8, ENST00000338799.9, ENST00000406599.5, ENST00000427531.6, ENST00000440973.5, ENST00000443427.5, ENST00000456483.3 ) - Associated Disease
- Malignant neoplasm of prostate
- Source Database
- DisGeNET
- Description
- The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.
- Pubmed
- 24859835
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.0437246807115603
- Year of publication
- 2014
Drugs